Depressive disorder (Vishada)

Role Of Combined Efficacy Of Virechana, Basti, Pratimarsha nasya, Shiropichu and Unmadakutara rasa In Vishada (Depressive disorder) An Open Labelled RCT Study - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086088

Enrollment

Registered

2025-05-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F339- Major depressive disorder, recurrent, unspecified

Interventions

Intervention1: 1. Unmadakutahara rasa 2. Saraswatadi kashaya: Dose 1.500mg BID A/F 2.20ml as Anupana BID A/F Control Intervention1: Amitriptyline: Dose- 25 mg 1tab BID A/F Control Intervention2: SS

Eligibility

Inclusion criteria

Inclusion criteria: Patients who fulfill diagnostic criteria of Vishada (Depressive disorder) Patients who is diagnosed with depression. Patients who will sign informed consent form

Exclusion criteria

Exclusion criteria: Patients having complicated diseases which requires major intervention. Patients with active suicidal tendency. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Improvement in Parameters like WHO ICD-11 For Depressive disorder Hamilton Depression Scale Dukha,Anidra, arati, karneshu avasada, Parajaya , Atichintanam , amarsha and gadodvegaTimepoint: 6weeks 6days	—

Secondary

Measure	Time frame
Improvement in Serum Lithum Serum magnesium TSH weightTimepoint: 6weeks6days	—

Countries

India

Contacts

Public ContactDr Mahima goswami

Taranath Government Ayurvedic Medical College and Hospital, Bellary, Karnataka

drmvdbly@gmail.com9844094290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026